ACM
MRVI icon

ADAR1 Capital Management’s Maravai LifeSciences MRVI Stock Holding History

ADAR1 Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-700
Closed -$5.82K – 273
2024
Q3 		$5.82K Buy
+700
New +$6.05K ﹤0.01% 262
2024
Q2 		– Sell
-1,000
Closed -$8.67K – 305
2024
Q1 		$8.67K Buy
+1,000
New +$6.77K ﹤0.01% 231

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ADAR1 Capital Management's MRVI Position: Q4 2024 in Review

ADAR1 Capital Management sold out of Maravai LifeSciences (MRVI) in Q4 2024, closing a stake of 700 shares — an estimated $5.82K sold.

ADAR1 Capital Management first reported a position in MRVI in Q1 2024 and held it in 2 quarters. The position peaked at $8.67K in Q1 2024. 185 funds tracked by Wall St. Rank hold MRVI as of Q4 2024.

  • ADAR1 Capital Management reported no remaining Maravai LifeSciences position as of Q4 2024 after selling out during the quarter.
  • ADAR1 Capital Management sold 700 Maravai LifeSciences shares in Q4 2024, an estimated $5.82K.
  • ADAR1 Capital Management first reported a position in Maravai LifeSciences in Q1 2024 and held it in 2 quarters.
  • ADAR1 Capital Management's Maravai LifeSciences position peaked at $8.67K in Q1 2024.
  • 185 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2024.

Based on ADAR1 Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.